These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3491540)

  • 1. Heterogeneity in type IIB von Willebrand disease: two unrelated cases with no family history and mild abnormalities of ristocetin-induced interaction between von Willebrand factor and platelets.
    Federici AB; Mannucci PM; Bader R; Lombardi R; Lattuada A
    Am J Hematol; 1986 Dec; 23(4):381-90. PubMed ID: 3491540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
    Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
    Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.
    Holmberg L; Berntorp E; Donnér M; Nilsson IM
    Blood; 1986 Sep; 68(3):668-72. PubMed ID: 3488775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
    Cooney KA; Lyons SE; Ginsburg D
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation.
    Saba HI; Saba SR; Dent J; Ruggeri ZM; Zimmerman TS
    Blood; 1985 Aug; 66(2):282-6. PubMed ID: 3926021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New variant of type II von Willebrand's disease with structural abnormality of plasma von Willebrand factor in a patient with very mild bleeding history.
    Baillod P; Gaucher C; Affolter B; Mazurier C; Pflugshaupt R
    Am J Hematol; 1995 May; 49(1):21-8. PubMed ID: 7741134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP; Montgomery RR
    Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF).
    Mannucci PM; Lombardi R; Federici AB; Dent JA; Zimmerman TS; Ruggeri ZM
    Blood; 1986 Jul; 68(1):269-74. PubMed ID: 3487357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New families with von Willebrand disease type 2M (Vicenza).
    Zieger B; Budde U; Jessat U; Zimmermann R; Simon M; Kätzel R; Sutor AH
    Thromb Res; 1997 Jul; 87(1):57-64. PubMed ID: 9253800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
    De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional variant of type I von Willebrand disease.
    Tavori S; Tatarsky I
    Am J Hematol; 1987 Feb; 24(2):189-97. PubMed ID: 3101492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease.
    Mannucci PM; Lattuada A; Castaman G; Lombardi R; Colibretti ML; Ciavarella N; Rodeghiero F
    Blood; 1989 Nov; 74(7):2433-6. PubMed ID: 2804373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity.
    Federici AB; Mannucci PM; Lombardi R; Lattuada A; Colibretti ML; Dent JA; Zimmerman TS
    Am J Hematol; 1989 Dec; 32(4):287-93. PubMed ID: 2510503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.
    Ruggeri ZM; Lombardi R; Gatti L; Bader R; Valsecchi C; Zimmerman TS
    Blood; 1982 Dec; 60(6):1453-6. PubMed ID: 6982737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():435-451. PubMed ID: 28804846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.